Mimedx (MDXG) Return on Invested Capital Growth (5y) (2018 - 2026)

Mimedx (MDXG) Return on Invested Capital Growth (5y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Mimedx 635.35 Mn 475.58 Mn 41.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.00
Dec 31, 2025 13.00
Sep 30, 2025 11.00
Jun 30, 2025 7.00
Mar 31, 2025 8.00
Dec 31, 2024 11.00
Sep 30, 2024 34.00
Mar 31, 2018 5.00